The GnRH Receptor Antagonists Market continues to expand as endocrinologists, oncologists, and reproductive medicine specialists increasingly favor these agents for their rapid onset of action and reduced hormonal flare compared to traditional GnRH agonist therapies. With GnRH receptor antagonists demonstrating clinical utility across prostate cancer, endometriosis, uterine fibroids, assisted...